Search

everythinglearnresearchcommunity

for

Search:↓

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.

Iron deficiency might be linked to hair loss, but more research is needed.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Skin symptoms appear in up to 20% of Covid-19 cases.

Intermittent iron and nutritional supplements can help reduce hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

COVID-19 symptoms range from mild to severe, with older adults at higher risk.

Certain natural compounds called terpenes may help prevent prostate cancer.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Some dibenzo compounds might help treat cancer with fewer side effects.

Certain alkaloids could help create new coronavirus drugs.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Testosterone's effects on COVID-19 are unclear and need more research.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Cepharanthine shows promise as a COVID-19 treatment.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.